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Abstract
Background: Stroke can result in death and long-term disability. Fast and high-quality care can reduce the impact
of stroke, but UK national audit data has demonstrated variability in compliance with recommended processes of
care. Though quality improvement collaboratives (QICs) are widely used, whether a QIC could improve reliability
of stroke care was unknown.
Methods: Twenty-four NHS hospitals in the Northwest of England were randomly allocated to participate either
in Stroke 90:10, a QIC based on the Breakthrough Series (BTS) model, or to a control group giving normal care.
The QIC focused on nine processes of quality care for stroke already used in the national stroke audit. The nine
processes were grouped into two distinct care bundles: one relating to early hours care and one relating to
rehabilitation following stroke. Using an interrupted time series design and difference-in-difference analysis, we
aimed to determine whether hospitals participating in the QIC improved more than the control group on
bundle compliance.
Results: Data were available from nine interventions (3,533 patients) and nine control hospitals (3,059 patients).
Hospitals in the QIC showed a modest improvement from baseline in the odds of average compliance equivalent
to a relative improvement of 10.9% (95% CI 1.3%, 20.6%) in the Early Hours Bundle and 11.2% (95% CI 1.4%, 21.5%)
in the Rehabilitation Bundle. Secondary analysis suggested that some specific processes were more sensitive to
an intervention effect.
Conclusions: Some aspects of stroke care improved during the QIC, but the effects of the QIC were modest
and further improvement is needed. The extent to which a BTS QIC can improve quality of stroke care remains
uncertain. Some aspects of care may respond better to collaboratives than others.
Trial registration: ISRCTN13893902.
Keywords: Stroke, Quality improvement, Breakthrough series collaborative, Trial
Background
Quality improvement collaboratives (QICs) bring together
multidisciplinary teams across different organizations to
work over a period of time towards defined improvement
goals [1]. Though QICs have enjoyed enduring popularity
as a means of securing improvement, evidence to support
their effectiveness is equivocal [2]. This may be because
studies of collaboratives have often used weak designs
that are biased in favor of positive findings, tend towards
measurement error, and perform poorly in ruling out
alternative explanations for any improvement detected,
including secular trends [3,4]. Further, collaboratives may
tackle complex, multi-faceted interventions, some of
which may have weak underlying evidence for their effect-
iveness [5]. In this article, we report a cluster-randomized
trial of a QIC based on the Breakthrough Series (BTS)
model that sought to improve compliance with processes
associated with high-quality stroke care in hospitals in the
Northwest of England.
Stroke affects up to 15 million people per year world-
wide [6]. Of these, 17% die within one month. Survivors
often suffer long-term disability, resulting in increased
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substantially mitigated by optimal care, but data from
the 1990s showed that UK patients had poorer outcomes
than many European countries [7]. For the last decade,
the English National Sentinel Audit of Stroke (hereafter
‘National Audit’) has collected data biennially from hos-
pitals in England and Wales on over two hundred mea-
sures of stroke care [8]. This has revealed dramatic
variation in the care provided by different organizations,
and has identified nine evidence-based processes associ-
ated with improved outcomes [9]. In 2008, prior to the
commencement of this research, National Audit data
indicated that stroke care in the Northwest of England
was among the worst in the UK; for example, only four of
every ten patients received a brain scan within 24 hours.
Stroke 90:10 was a BTS collaborative that aimed to
improve compliance to an average of 90% on each of the
nine processes by the next National Audit (2010), up
from the baseline average of 72% in 2008. The nine
processes targeted by the collaborative were in effect pre-
defined, since they had already been selected as the basis
of performance assessment for the National Audit. How-
ever, the aims of Stroke 90:10 went beyond simply enhan-
cing reported performance on the national measures. The
QIC sought to improve not just average compliance, but
also reliability. Reliability was defined to mean reducing
variation and delivering higher levels of consistent per-
formance. To motivate and assess reliability, the nine key
processes were organized into two care bundles: one for
early hours care (Bundle 1) and one for rehabilitation
(Bundle 2) [10].
We conducted a cluster randomized controlled trial
with an interrupted time series design to determine
whether hospitals participating in the Stroke 90:10
collaborative improved more than non-participating con-
trols, as assessed by compliance with the two bundles of
care. We compared across collaborative and control hos-
pitals the amount of improvement on bundle compliance.
Quality improvement collaboratives
A QIC is an organized, multifaceted approach to quality
improvement that involves five essential features: an
agreed topic and aim; clinical and quality improvement
experts who provide support for improvement by acting
as a faculty; multi-professional teams from multiple sites
who participate in the QIC; use of an agreed model for
improvement (for example, setting an aim, collecting
data and testing changes); and the collaborative process
involves a series of structured activities including face-to
face-meetings [5].
As well as mastering quality improvement techniques
and applying them in their own organizations, teams par-
ticipating in QICs are encouraged to create a sense of com-
mon purpose and commitment, to generate enthusiasm,
mutual support, and shared learning [11]. Several variants
of QIC models exist, with the Institute of Healthcare
Improvement’s BTS design among the most widely used
[1]. A BTS collaborative typically involves collaborative fac-
ulty comprising quality improvement experts, three learn-
ing sessions (collaborative meetings), and action periods
where participants implement activities, including Plan-
Do-Study Act (PDSA) cycles. QICs are often used to
implement evidence-based processes grouped into care
‘bundles’ or composites of processes. Behind the concept
of bundles is the idea that groups of interrelated processes,
rather than individual processes, are the appropriate target
both for standards of practice and for analysis [12]. Bundles
require that all patients receive all elements of the bundle
(or have documented evidence of valid exception). There is
also a theory that the bundle as a whole will achieve better
results than the sum of its parts [13].
The stroke 90:10 QIC
The Stroke 90:10 collaborative ran from July 2008 to
December 2010, with participating organizations recruited
between July and December 2008. Participating site teams
received an extensive package of support from the pro-
gram office, which was based at Salford Royal Hospitals
NHS Trust. Support included executive mentoring visits;
direct access to the Stroke 90:10 project director; an
improvement advisor and one another via a web-based
portal (extranet); and weekly online sharing and learning
sessions. Teams were asked to produce monthly reports
to reflect on their performance. The project director (au-
thor MP) also met with each hospital’s chief executive and
the team to review progress twice.
All hospitals participating in the collaborative were
asked to commit to:
1. appointing an executive lead, a physician leader, a
site lead, and a project team comprising relevant
leaders from clinical and ward areas;
2. taking part in one two-day and two one-day
learning sessions, 90 days apart, that provided
instruction in the theory and practice of
improvement, offered teams advice and guidance,
and shared cumulative results;
3. participating in ongoing collaborative activities over
the course of the program;
4. using ‘The Model for Improvement’ to implement
changes at the point of care and test them for local
feasibility, reliability, and evidence of improvement
in relation to the two bundles of processes relating
to stroke care (Table 1)[ 14];
5. collecting data on 20 randomly selected patients
per month;
6. submitting the data to a bespoke web-based system
linked to the National Audit.
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Study design
A cluster randomized controlled trial was used with an
interrupted time series design to compare the hospitals
participating in the Stroke 90:10 QIC with the non-
participating controls. The study sought to compare the
amount of improvement on the two evidence-based
bundles of care (early hours and rehabilitation) used in
the QIC.
This study was approved by Tameside and Glossop
Research Ethics Committee (Ref: 08/H1013/55) and was
registered as a clinical trial with the International Stand-
ard Randomized Controlled Trial Number Register (Ref:
ISRCTN13893902).
Setting and participants
All NHS hospital Trusts in the Northwest of England
were invited to participate based on the pre-defined in-
clusion criteria of: a minimum of ten inpatient dedicated
stroke beds (a ‘stroke unit’); agreement to participate
signed by the chief executive; agreement to participate
from a consultant in stroke medicine (or equivalent); a
dedicated multidisciplinary stroke team; and availability
of case notes for review.
Randomization
We used a stratified-randomization approach. Hospitals
were stratified by stroke performance (Sentinel Audit
score above or below 60) in the 12 months preceding
baseline data collection (2007 and 2008). Within each
group, a computer-generated list was used to randomly
allocate 12 hospitals to the intervention group and 12 to
the control group. The intervention group took part in
the QIC from January to October 2009, but the control
group did not join the QIC until January 2010. The
control group of hospitals, who waited to join the QIC,
provided an ‘untreated’ control group. The nature of the
trial meant that participants could not be blinded to
group allocation.
Sample size
A conservative approach to the power calculation was
undertaken, based on a simple baseline average versus
end of study average comparison. This was preferable to
basing the power calculation on an interrupted time
series using a fixed number of charts per month, because
we did not know in advance how the sites would choose
to implement their activities or the likely impact of these
activities (for example, in a simple linear fashion, stepped
or incremental, or any other way).
Various permutations of the power calculation were
performed. Using data from the 2008 National Stroke
Audit, the intra-class correlation coefficient was estimated
at 0.149 for Bundle 1 and 0.217 for Bundle 2. Based on
preliminary data, where at one hospital, compliance with
Bundle 2 had improved to 80%, we assumed a 0.05 signifi-
cance level, 90% power and a minimum detectable differ-
ence of 25% for Bundle 1 and 35% for Bundle 2 in relative
increased uptake between the control and intervention.
We estimated that for improvement on Bundle 1 to reach
significance, up to 24 hospitals, with 12 on either arm,
would be required (based on the control group improving
to 40% compliance and the intervention group improving
to 65% compliance). For Bundle 2 to reach significance,
Table 1 Care bundles for stroke 90:10
Early hours (Bundle 1) 1. Brain imaging within 24 hours of admission to hospital (CT scan) to confirm stroke type (ischaemic or haemorrhagic)
and determine management.
2. Delivery of aspirin or an alternative antiplatelet (for patients where an antiplatelet is clinically indicated)
within 24 hours of admission to modulate stroke complications and improve outcomes. For shorthand, we refer
to this as ‘aspirin.’
3. Swallow screen within 24 hours of admission, to prevent unnecessary withdrawal of nutrition, support timely
administration or modification of aspirin/antiplatelet delivery and highlight patients who need on-going
management of swallow safety.
4. Weight assessment on admission, as a marker of the likelihood of repeated weighing and diligent management
of nutrition.
Rehabilitation (Bundle 2) 1. Physiotherapy assessment within 72 hours of admission to improve early mobilization, and increased likelihood
of targeted goal setting.
2. Occupational therapy assessment within 4 days of admission to support activities of daily living, memory,
perception and cognition.
3. Mood assessment (during the in-patient stay) to screen for altered mood and other factors, given that post-stroke
depression is known to affect the likelihood of long-term recovery.
4. Documented evidence of MDT goals set for rehabilitation as a marker of patient involvement in care and
multidisciplinary team working.
5. 50% of the patient’s hospital stay on a stroke unit, defined using the National Audit criteria, given evidence
that stroke units reduce mortality and improve patient outcomes.
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(based on the control group improving to 45% compliance
and the intervention group improving to 70% compliance).
Outcomes and follow-up
Participating hospitals provided data to the QIC separately
and independently from the National Audit (Table 2),
although both were measuring the same processes.
Random samples of 20 patients per month per hospital
were used to generate data for both the intervention
period (July 2008 to December 2009) and baseline pre-
intervention period (July 2008 to December 2008).
The primary measures for the trial were compliance
with Bundle 1 and Bundle 2. The elements measured
within those bundles were identical to the indicators
used for the National Audit [8]. Bundle compliance was
calculated using an ‘all or none’ measurement, where
every process element of the bundle had to be under-
taken for overall bundle compliance to be achieved [15].
Thus, omission of any one or more elements would
result in a patient’s care being deemed ‘bundle non-
compliant’ as illustrated in Figure 1.
Data collection
Once the QIC began in January 2009, intervention teams
were asked to submit, every month, a complete registry
of discharged patients coded for stroke from the previ-
ous month (based on ICD 10 codes 61, 63, and 64). Each
month, the Stroke 90:10 faculty used this registry to pro-
duce the random sample of 20 patients for each hospital
to audit. For each of the 20 patients included in the sam-
ple, data were collected on 45 questions (excluding basic
demographic information) on compliance with elements
of Bundle 1 and Bundle 2, the three stages of acute
stroke care: stroke onset and hospital stay; comorbidities
and risk factors; and standards by discharge. Data were
entered into a web-based database developed in partner-
ship with the Royal College of Physicians.
The QIC faculty collected the data for the baseline
period for hospital teams in the intervention group, and
throughout the entire study period for those in the con-
trol group. After the baseline period the intervention
group were expected to collect and submit data them-
selves, though they sometimes required extensive faculty
support to do so.
In both the control and intervention groups, hospitals
were asked to audit all patients in months where there
were fewer than 20 admissions. Where patient records
were incomplete, could not be retrieved, or were mis-
coded, patients were excluded and replaced by the next
available patient. In total, 1,328 (17%) records (control
and intervention) were excluded (see Figure 2).
Statistical analysis
We used a difference-in-difference approach to compare
the differences between the intervention and control
groups on bundle compliance. This approach measures
the difference in bundle compliance over time (before
and after the intervention) for the intervention group
compared with the difference over the same period for
the control group. The analysis was carried out using
Table 2 Baseline information for individual data (patient
level)
Intervention Control P
Male 2,287 48.2% 2,502 47.3% 0.559
Comorbidities
Atrial fibrillation 714 15.1% 768 14.5% 0.457
Previous stroke or TIA 1,299 27.4% 1,404 26.6% 0.328
Diabetes mellitus 735 15.5% 742 14.0% 0.178
Hyperlipidaemia 647 13.6% 735 13.9% 0.942
Hypertension 2,087 44.0% 2,122 40.1% 0.135
Myocardial infarction or angina 777 16.4% 705 13.3% 0.019
Valvular heart disease 150 3.2% 118 2.2% 0.188
Cardiac failure 113 2.4% 135 2.6% 0.899
Risk factors
Smoker 806 17.0% 765 14.5% 0.064
Ex smoker 733 15.5% 903 17.1% 0.453
Alcohol excess 275 5.8% 304 5.7% 0.692
Patient independent pre stroke 3,285 69.3% 4,031 76.2% 0.384
Readmitted within 28 days 356 7.5% 308 5.8% 0.223
Patient died as inpatient 1,006 21.2% 1,011 19.1% 0.189
Alive at 30 days 3,646 76.9% 3,834 72.5% 0.835
Patient received antibiotics for a
newly acquired pneumonia
during admission after stroke
298 6.3% 298 5.6% 0.729
Patient had urinary tract infection
in first seven days of admission
defined by a positive culture or
clinically treated
159 3.4% 144 2.7% 0.514
Motor deficits in first 24 hrs
of admission
2,534 53.4% 2,795 52.9% 0.727
Dysphasia in first 24 hrs
of admission
1,588 33.5% 1,753 33.2% 0.748
Dysarthria in first 24 hrs
of admission
1,549 32.7% 1,526 28.9% 0.808
Motor deficits in first 24 hrs
of admission
2,534 53.4% 2,795 52.9% 0.879
Patient worst level
of consciousness
0.992
Unconscious 527 11.1% 507 9.6%
Confused 264 5.6% 248 4.7%
Drowsy 657 13.9% 884 16.7%
Fully conscious 2,933 61.9% 3,575 67.6%
Not known 360 7.6% 73 1.4%
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Using a pre-post-test methodology, we aimed to deter-
mine whether there was a difference in relative average
bundle compliance in the last three months of the base-
line period (October 2008 to December 2008) compared
with the last three months of the collaborative (October
2009 to December 2009). Specifically, we sought to
determine a difference in difference of means. We fitted
a logistic regression model with a random effects term
to take account of clustering at the hospital level. Bundle
compliance was the primary measure. Explanatory
variables included group (control or intervention), time
period (October 2008 to December 2008 and October
2009 to December 2009) and an interaction term between
them. The interaction term provides the difference in dif-
ferences that estimates the impact of the collaborative.
Results
Of the 25 eligible trusts in the Northwest of England, 24
(covering 30 hospitals) agreed to participate and were
randomized (Additional file 1). Of these, data were avail-
able from 18 trusts for analysis (Figure 2), yielding 3533
patients in the intervention arm and 3,059 patients in
the control arm. Comparisons of patient demographic
and clinical data between the control and intervention
groups (Table 2) suggested no significant differences at
baseline, except that the intervention group patients
showed higher co-morbidity from myocardial infarction or
angina (16.4% versus 13.3%; p =0.019). The collaborative
Figure 1 Bundle compliance. In this example only patient 3 would be classed as receiving care that was bundle compliant.
Figure 2 Flow diagram of participation.
Power et al. Implementation Science 2014, 9:40 Page 5 of 9
http://www.implementationscience.com/content/9/1/40program was run as designed. However, hospital sites did
not consistently audit 20, or all, patients each month.
Figure 2 shows that a small number of hospitals were
excluded for having a reporting rate under 50%; this was
pre-specified in the protocol.
Primary measures
Bundle 1 (early hours)
Average Bundle 1 compliance in the control group at
baseline (October 2008 to December 2008) was 24.3%,
rising to 37.5% by study end (Figure 3). In the interven-
tion group, compliance was 19.6% at baseline, rising to
42.3% by study end. Using a difference-in-difference
approach, this represents a relative increase in the odds
of compliance of 1.56 (95% CI 1.06, 2.31 p = 0.025) in
the intervention group compared with the control group
(Table 3). These odds are equivalent to a relative im-
provement by the end of the study of 10.9% (95% CI
1.3%, 20.6%) in the intervention group relative to the
control group.
Secondary analysis found, within the bundle processes,
that the largest relative difference was seen in administer-
ing aspirin (or an alternative antiplatelet) within 24 hours
of admission. The odds of aspirin (or suitable alternative)
administration to patients where it was clinically indicated
in the intervention relative to the control group increased
by 1.52 (95% CI 1.05, 2.2 p=0.027).
Bundle 2 (rehabilitation bundle)
Baseline bundle compliance with Bundle 2 in the control
group was 21.9%, rising to 33.2% by study end. In the
intervention group, baseline compliance was 27.3% and
rose to 46.2% by study end (Figure 3). Using a difference-
in-difference approach, this represents an increase in the
odds of compliance of 1.61 (95% CI 1.07, 2.42 p = 0.023)
in the intervention group compared with the control
group. These odds are equivalent to a relative improve-
ment by the end of the study of 11.2% (95% CI 1.4%,
21.5%) in the intervention group relative to the control
group (Table 3).
Secondary analysis found that for the individual pro-
cesses included in the bundle, both Mood Assessed during
Hospital Admission (odds 1.74, 95% CI 1.17, 2.58; p=
0.006) and Rehabilitation Goals set by multidisciplinary
teams MDT (odds 2.43, 95% CI 1.7, 3.47; p<0.001) in-
creased in the intervention group more than in the con-
trol group.
Discussion
Our study is among a small number of studies evaluating
the effectiveness of a QIC that have used a controlled
design. Like others [9,16], we have found evidence of im-
provement in both the intervention and control groups
pointing to an underlying secular trend of incremental im-
provement over time. Some of the reasons for this are
likely to lie with the unprecedented national and regional
attention on stroke coinciding with the period of study.
During this time, managed clinical networks for stroke
were being developed, a National Audit Office report was
published and the Department of Health Stroke Improve-
ment program was launched [17]. Delivery of thromboly-
sis was a national target, and the basic processes required
for success in achieving this were closely linked to the
processes of care packaged into our Early Hours bundle.
Given the intensity of focus, it is unsurprising that both
intervention and control groups demonstrated improved
Figure 3 Bundle compliance over time in the control and intervention group. In bundle 1, for the control group, compliance went from
24.3% to 37.5% (13.2% change) and in the intervention group, from 19.6% to 42.3% (22.7% change). On crude comparison, this is a difference of
9.5%, but with all the various adjustments for clustering, this results in a relative benefit of 10.9% in the intervention relative to the control group.
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signal the collective impact of direction setting (through
national policy), implementation of national standards,
regulation, clinical leadership, research implementation
and other activities in creating a ‘rising tide’ of more reli-
able care for stroke patients.
Participation in a QIC does appear to offer a modest
overall effect in the amplitude of change over and above
secular trend. At first glance it may seem disappointing
that the overall benefits are not more significant. How-
ever, the bundled nature of our primary outcome mea-
sures may have obscured some important and significant
effects. These include the disproportionate impact of
Stroke 90:10 on some process indicators of quality of
care and the resistant nature of others. Looking at the
bundles of care as individual items, it is possible to see
that four care processes (administration of aspirin/
antiplatelet, weighing patients on time, mood assessment
and setting MDT rehabilitation goals) improved signifi-
cantly in the group of hospitals that participated in the
collaborative. Weighing patients and setting MDT goals
conferred a 17% and 21% absolute improvement respect-
ively. One possibility, therefore, is that the effects of
QICs may be specific rather than generalized: some pro-
cesses of care may be more susceptible to the improve-
ment methods used in a collaborative program than
others. This is an important new hypothesis that requires
further testing. Furthermore, it appears that these pro-
cesses could have some distinctive characteristics: they are
(relatively) simple changes under the direct control of the
hospital stroke team on the stroke unit (defined as a phys-
ical unit and not a collection of staff and services) and
they are geographically bounded. This possible explan-
ation is supported somewhat by an Australian study in
Table 3 The proportion of patients who received the bundle in the three months prior to the start of the collaborative
intervention (October 2008 to December 2008) were compared with the proportion who received the bundle in the
three months at end of the intervention (October 2009 to December 2009)
Compliance: Proportion (%) Difference in differences of averages
Control group Intervention group
Oct-Dec
2008
Oct-Dec
2009
Oct-Dec
2008
Oct-Dec
2009
Odds ratio 95% CI
Percent relative improvement
P ICC*
Early hours (Bundle 1) 122/502 212/566 114/583 258/610 1.56 (1.06, 2.31) 0.025 0.066
24.3% 37.5% 19.6% 42.3% 10.9% (1.3%, 20.6%)
Brain Scan within 24 hrs of Hospital
Admission
316/481 435/556 353/568 455/603 0.95 (0.65, 1.4) 0.799 0.064
65.7% 78.2% 62.1% 75.5% -0.9% (-8.6%,5.4%)
Aspirin in 24 hrs of hospital Admission 151/392 258/463 115/436 261/505 1.44 (0.96, 2.15) 0.079 0.051
38.5% 55.7% 26.4% 51.7% 9% (-1%,18.8%)
Swallowing Screening Recorded in 24 hrs
of Hospital Admission
220/422 350/500 326/495 426/523 1.09 (0.71, 1.67) 0.7 0.162
52.1% 70% 65.9% 81.5% 2% (-8.4%,11.2%)
Weighed during Hospital Admission 258/415 346/504 286/491 462/525 4.4 (2.75, 7.03) <0.001 0.158
62.2% 68.7% 58.2% 88% 26.2% (20.1%,30.6%)
Rehabilitation (Bundle 2) 110/502 188/566 159/583 282/610 1.61 (1.07, 2.42) 0.023 0.197
21.9% 33.2% 27.3% 46.2% 11.2% (1.4%,21.5%)
Ward of 50 percent+ of stay 325/502 414/566 384/583 473/610 1.17 (0.8, 1.72) 0.412 0.091
64.7% 73.1% 65.9% 77.5% 3.0% (-4.6%,9.3%)
Physiotherapist assessment in 72 hrs
of Hospital Admission
325/502 414/566 384/583 473/610 1.6 (0.98, 2.6) 0.06 0.119
64.7% 73.1% 65.9% 77.5% 9% (-0.4%,16.1%)
Occupational Therapist Assessment in 4 days
of Hospital Admission
302/406 393/495 394/490 479/534 1.06 (0.68, 1.67) 0.789 0.234
74.4% 79.4% 80.4% 89.7% 1.4% (-9.5%,11.1%)
Mood Assessed during Hospital Admission 235/388 354/478 330/469 419/515 2.68 (1.69, 4.26) <0.001 0.247
60.6% 74.1% 70.4% 81.4% 24.1% (12.9%,34%)
Rehabilitation Goals set during Hospital
Admission agreed by MDT
147/407 226/488 192/478 315/512 5.43 (3.26, 9.05) <0.001 0.194
36.1% 46.3% 40.2% 61.5% 35.8% (27.3%,41.9%)
*ICC: The Intraclass Correlation Coefficient indicates the variation due to patients being clustered within hospitals. The ICC estimates shown here are derived from
the associated random effects model.
In line one the numerator is the number of patients who received all four process measures; the denominator is the total number surveyed in the three
month period.
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ments in direct patient care, delivered on a ward, can be
made using a collaborative method [18].
Processes of care that are less tractable may require
more attention to engineering systems and processes. For
example, delivering a CT scan within hours of admission
requires coordination of multiple services and provider
groups. Achieving the necessary changes in patterns of
working, culture, and attitudes requires an approach dif-
ferent from that used for less socially complex problems.
Our study may thus provide some evidence to suggest that
the effects of QICs, rather than being uniform, may be
mediated by the nature of the processes being targeted
and the amount of control participants have over them.
Collaboratives may be more suitable for some kinds of im-
provement interventions than others, and future research
should investigate this possibility further. The kinds of im-
plementation interventions needed to support more com-
plex organizational change also require further study, now
that promising examples are beginning to emerge [19-24].
Limitations
Though our study design represents improvement on
the weaker designs typically used in evaluations of col-
laboratives, it does have some limitations. First, because
the nine processes used in the study were those used by
the National Audit, we may not have captured other
processes of care that are clinically more important.
Variation in data collection approaches across hospitals,
although small, may have introduced bias to the results.
Second, six hospitals did not provide data, and there was
some variation in completeness rates between hospitals.
This may introduce bias because it is unlikely the hospi-
tals that failed to provide data, or did not produce
complete data, were similar to those that did. Third,
generalizability beyond an English context is limited.
The socio-technical nature of this intervention, and the
context within which it was set, suggests that it is not
clear whether the same effects would be found in other
populations or settings.
Fourth, our study was not designed to explain whether
the increased process adherence resulted in improved out-
comes or had any unintended consequences, for example
longer lengths of stay or increased re-admissions to hos-
pital. Future studies should investigate the possibility that
there may be some causal mechanism that links improved
performance on the nine processes to beneficial or un-
wanted outcomes. Finally, beyond evaluations of collabo-
ratives, experimental evaluations of many complex socio-
technical interventions demonstrate modest effect sizes,
which might suggest the limitations of positivist evalua-
tions in this context and signal a requirement for more so-
phisticated evaluation approaches. Some of these issues
are the subject of an accompanying paper [25].
Conclusions
Our study suggests that the answer to whether a Break-
through Series QIC can deliver the extra boost needed to
induce improvement beyond secular trend is not straight-
forward. It does appear to support improvement in more
consistent delivery of some processes of care grouped into
bundles, but additional, or other kinds of, support may be
needed for more complex organizational challenges. Our
study reinforces the need, when researching health service
improvements, for controlled studies using difference-in-
difference analyses to avoid mistaking secular trends for
treatment effects. Delivering consistently high quality of
stroke care remains a key challenge.
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